TAL1 (T-cell acute leukemia 1)

1998-03-01   Marie-Claude Labastie  , Jean-Loup Huret  

Institut dEmbryologie Cellulaire et Moléculaire, CNRS FRE 216O, 94736, Nogent-sur-Marne Cedex, France

Identity

HGNC
LOCATION
1p33
LOCUSID
ALIAS
SCL,TCL5,bHLHa17,tal-1
FUSION GENES

DNA/RNA

Atlas Image
DNA diagram

Description

8 exons; 16 kb; SIL (a different gene) sits 90 kb further in 5

Transcription

(complex) alternate splicing of: 1A with 2A, or 3 vs 1B, 2B,3 ...or directly 4, 5, 6

Proteins

Description

331 amino acids for the major form of 48 KDa; a truncated form of 26 KDa only in some T-ALL; domains: prolin rich in N-trem; poly Gly; basic Helix-Loop-Helix from the exon 6.

Expression

in hematopoietic stem cells, erythroid and megakaryocytic lineages of the adult and in the embryonic brain; indispensable for the genesis of the hematopoietic system.

Function

transcription factor; exhibits sequence-specific DNA binding activity when in dimers with another bHLH protein such as E2A (DNA specific sequences are: CANNTG, especially: CAGATG); direct interactions of the bHLH with the LIM domain of RBTN2 or RBTN1.

Homology

TAL2 in 9q32; LYL1 in 19p13; more distantly: MYC and other members of the MYC family of Helix-Loop-Helix transcription factors.

Implicated in

Entity name
t(1;7)(p32;q34) or t(1;14)(p32;q11)/T-ALL --> TAL1 - TRB or TAL1 -TRD
Disease
T-cell ALL
Prognosis
is not too poor, compared to other T-ALL
Entity name
T-ALL with normal karyotype, but with submicroscopic deletions of part of TAL1 in the 5 region --> SIL - TAL1
Disease
found in 10 to 30 % of T-ALL with a normal karyotype
Hybrid gene
deletions which place SIL (SCL interrupting sequence) in close 5 of TAL1; hybrid gene with exon 1 from SIL.
Fusion protein
TAL1 is under the promoter sequences controle of SIL, a gene active during T cell development.
Entity name
t(1;3)(p32;p21)/T-ALL --> TAL1 - TCTA
Disease
T-cell ALL

Breakpoints

Atlas Image

Note

mainly in 5 in a 1 kb region; but also dispersed in rare cases

Article Bibliography

Pubmed IDLast YearTitleAuthors
84717691993Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.Bash RO et al
87603031996The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.Hofmann TJ et al
90201851997Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.Ono Y et al
75681771995Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.Osada H et al
86896861996The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.Porcher C et al
79570521994Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.Wadman I et al

Other Information

Locus ID:

NCBI: 6886
MIM: 187040
HGNC: 11556
Ensembl: ENSG00000162367

Variants:

dbSNP: 6886
ClinVar: 6886
TCGA: ENSG00000162367
COSMIC: TAL1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000162367ENST00000294339P17542
ENSG00000162367ENST00000371884P17542

Expression (GTEx)

0
5
10
15
20
25

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
381023372024Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.1
381023372024Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.1
366327362023TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.2
366327362023TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.2
336643682021Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).9
340754042021Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells.17
336643682021Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).9
340754042021Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells.17
320865282020Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.12
325936722020The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2.3
326336352020MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.7
328355482020SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.4
331775562020Dengue virus infection impedes megakaryopoiesis in MEG-01 cells where the virus envelope protein interacts with the transcription factor TAL-1.7
332936322020The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis.5
320865282020Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.12

Citation

Marie-Claude Labastie ; Jean-Loup Huret

TAL1 (T-cell acute leukemia 1)

Atlas Genet Cytogenet Oncol Haematol. 1998-03-01

Online version: http://atlasgeneticsoncology.org/gene/15/tal1-(t-cell-acute-leukemia-1)

Historical Card

1997-08-01 TAL1 (T-cell acute leukemia 1) by  Jean-Loup Huret,Marie-Claude Labastie 

Institut dEmbryologie Cellulaire et Moléculaire, CNRS FRE 216O, 94736, Nogent-sur-Marne Cedex, France